Tamiflu®/ Relenza® and Glucose-6-Phosphate Dehydrogenase
1
page
English
Documents
2009
Le téléchargement nécessite un accès à la bibliothèque YouScribe Tout savoir sur nos offres
1
page
English
Documents
2009
Le téléchargement nécessite un accès à la bibliothèque YouScribe Tout savoir sur nos offres
Publié par
Publié le
29 juillet 2009
Nombre de lectures
326
Langue
English
29/07/2009
Publié par
Publié le
29 juillet 2009
Nombre de lectures
326
Licence :
Langue
English
Tamiflu®/ Relenza®
and Glucose-6-Phosphate Dehydrogenase (G6PD) deficiency
Oseltamivir
(literature and pharmacovigilance)
Special recommendations for the attention of healthcare professionals
This medicine may be taken.
Instructions for the attention of patients with G6PD deficiency
This medicine may be taken.
Additional information
To date, no haemolytic risk has been identified in subjects with G6PD deficiency for oseltamivir.
Proprietary medicinal products
•TAMIFLU® ,•Lm/IgMmA2T1 UrLeFdwop for oral IFLU®®el paus,gc 75m54
sus e
• TAMpIFnLsUio®30, mgpsca ee luulT MA•capsmg, n
Zanamivir
(literature and pharmacovigilance)
Special recommendations for the attention of healthcare professionals
This medicine may be taken.
Instructions for the attention of patients with G6PD deficiency
This medicine may be taken.
Additional information
To date, no haemolytic risk has been identified in subjects with G6PD deficiency for zanamivir.
Proprietary medicinal products
•RELENZA® in single dose container5mg per dose, powder for inhalation
Afssaps, 07/29/2009
